Medicines update

The TGA has approved a new treatment for asthma and COPD, while a new laxative has been released in Australia, and GSK has launched its new Nicabate Oral Strips.

New asthma/COPD treatment approved

The TGA has this week approved a new treatment for asthma and COPD.

BreoEllipta, manufactured by  GSK Australia and Theravance,  is a combination of the inhaled corticosteroid (ICS), fluticasone furoate, and the long-acting beta2-agonist (LABA), vilanterol.

Two strengths of Breo Ellipta have been

Latest

Trending